Companies: 10,795·Total market cap: $144.5T
Kura Oncology, Inc.

Kura Oncology, Inc.

KURANASDAQHealthcare● Active
$8.57
$-0.18(-2.00%)
Market Cap$760352436
P/E Ratio
52W High$12.49
52W Low$5.45

Kura Oncology, Inc.(KURA)· 损益表

年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q(经 FMP 聚合)· 可在下方切换周期与 M/B/T 单位。

FMP · KURA · 截至 2026-06-08

财务报表

Revenue · Gross Profit · Net Income
Breakdown2025-122024-122023-122022-122021-12
Revenue
Revenue$67.48M$53.88M$0.00M$0.00M$0.00M
Cost of Revenue$0.06M$0.00M$0.85M$0.00M$0.00M
Gross Profit$67.42M$53.88M($0.85M)$0.00M$0.00M
Gross Margin %(computed)99.92%100.00%
Operating Expenses
R&D Expenses$251.07M$169.97M$115.23M$92.81M$84.72M
G&A Expenses$119.98M$77.11M$50.57M$47.05M$46.54M
Total Operating Expenses$371.06M$247.08M$164.96M$139.87M$131.26M
Operating Income($303.63M)($193.19M)($165.80M)($139.87M)($131.26M)
Operating Margin %(computed)-449.94%-358.55%
Interest Income$26.77M$22.85M$14.72M$4.25M$1.21M
Interest Expense$1.51M$1.62M$1.55M$0.23M$0.41M
Income Before Tax($278.37M)($171.97M)($152.63M)($135.84M)($130.47M)
Income Tax Expense$0.30M$2.02M$0.00M$0.00M$0.00M
Net Income($278.67M)($173.98M)($152.63M)($135.84M)($130.47M)
Net Margin %(computed)-412.95%-322.89%
Per Share & EBITDA
EPS (Basic)$-3.18$-2.02$-2.08$-2.03$-1.97
Wtd Avg Shares87.68M86.16M73.23M66.99M66.35M
EBITDA($275.82M)($169.50M)($150.23M)($134.85M)($129.49M)
EBITDA Margin %(computed)-408.74%-314.57%

数据来源:Financial Modeling Prep · 最后更新:2026-06-08 · USD · M

深入了解Kura Oncology, Inc.

关于Kura Oncology, Inc.(KURA)损益表

Kura Oncology, Inc.(KURA)损益表数据来源于SEC Form 10-K及10-Q申报文件。2025财年,KURA实现营收$0.07B,毛利润$0.07B(毛利率99.92%),净利润($0.28B)(净利率-412.95%)。

常见问题

KURA · 4 问

Kura Oncology, Inc.(KURA)2025财年营收为$0.07B,同比up25.2%。

KURA revenueKURA salesannual revenue YoYincome statement

· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-08